SILEXION THERAPEUTICS CORP (SLXN) Stock Earnings & Estimates
USA - NASDAQ:SLXN - KYG1281K1307 - Common Stock
3.4 USD
+0.01 (+0.29%)
3.47 USD
+0.07 (+2.06%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | ||||||
| EBITDA YoY % growth | N/A | N/A | N/A | -6M | -12.546M -109.09% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -200K | -770K -285.00% | -1.11M -44.16% | -6.045M -444.63% | -12.571M -107.94% | N/A 30.30% | N/A -17.82% | N/A -26.61% | N/A | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 92.88% | N/A 38.56% | N/A 1.08% | N/A -3.82% | N/A 26.41% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -3.47 88.61% | -1.93 99.38% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -2.363M 70.59% | -2.386M -25.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -4.32 | -3.67 | -0.65 | -17.65% |
| Q1 2025 Q2Q % growth | -3.90 | -3.37 | -0.53 | -15.86% |
| Q4 2024 Q2Q % growth | -311.40 | -14.99 | -296.41 | -1,976.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1260% | 0% | -1156.25% |
| Revenue | N/A | N/A | N/A | N/A |